F G Zitman1, J E Couvée. 1. Department of Psychiatry, BIP, PO Box 9600, 2300 RC Leiden, The Netherlands. f.g.zitman@lumc.nl
Abstract
BACKGROUND: Many patients with depression takebenzodiazepine drugs long term despite the absence of continuing therapeutic value. AIMS: To evaluate a treatment programme involving gradual discontinuation with or without simultaneous selective serotonin reuptake inhibitor (SSRI) prescribing and to determine the long-term outcome after benzodiazepine withdrawal. METHOD: Patients went through three phases - change to an equivalent dose of diazepam; subsequent randomisation to either 20 mg of paroxetine or placebo; and gradual reduction of diazepam in depression-free patients - with a follow-up after 2 or 3 years. RESULTS: A total of 230 patients were recruited and 75% in theparoxetine group and 61% in the placebo group were successfully treated after 6 weeks (P:=0.067). After 2 or 3 years 13% of patients were still benzodiazepine free: 26% of those who had successfully tapered off benzodiazepine and 6% of the total group. CONCLUSIONS: Transfer to diazepam followed by gradual withdrawal is an effective way of discontinuing chronic benzodiazepine use. The addition of SSRI treatment is of limited value.
RCT Entities:
BACKGROUND: Many patients with depression take benzodiazepine drugs long term despite the absence of continuing therapeutic value. AIMS: To evaluate a treatment programme involving gradual discontinuation with or without simultaneous selective serotonin reuptake inhibitor (SSRI) prescribing and to determine the long-term outcome after benzodiazepine withdrawal. METHOD:Patients went through three phases - change to an equivalent dose of diazepam; subsequent randomisation to either 20 mg of paroxetine or placebo; and gradual reduction of diazepam in depression-freepatients - with a follow-up after 2 or 3 years. RESULTS: A total of 230 patients were recruited and 75% in the paroxetine group and 61% in the placebo group were successfully treated after 6 weeks (P:=0.067). After 2 or 3 years 13% of patients were still benzodiazepine free: 26% of those who had successfully tapered off benzodiazepine and 6% of the total group. CONCLUSIONS: Transfer to diazepam followed by gradual withdrawal is an effective way of discontinuing chronic benzodiazepine use. The addition of SSRI treatment is of limited value.
Authors: Wim Gorgels; Richard Oude Voshaar; Audrey Mol; Eloy Van De Lisdonk; Jan Mulder; Henk Van Den Hoogen; Anton Van Balkom; Marinus Breteler; Frans Zitman Journal: Scand J Prim Health Care Date: 2008 Impact factor: 2.581
Authors: Richard C Oude Voshaar; Paul F M Krabbe; Wim J M J Gorgels; Eddy M M Adang; Anton J L M van Balkom; Eloy H van de Lisdonk; Frans G Zitman Journal: Pharmacoeconomics Date: 2006 Impact factor: 4.981
Authors: Irene J Zaal; Carolina F Spruyt; Linda M Peelen; Maarten M J van Eijk; Rens Wientjes; Margriet M E Schneider; Jozef Kesecioglu; Arjen J C Slooter Journal: Intensive Care Med Date: 2012-10-24 Impact factor: 17.440
Authors: Leonie Manthey; Fawzia van Loenen-Frösch; Erik J Giltay; Tineke van Veen; Klaske Glashouwer; Brenda W J H Penninx; Frans G Zitman Journal: Br J Clin Pharmacol Date: 2014-03 Impact factor: 4.335